犬2型腺病毒载体疫苗对豚鼠口蹄疫的保护作用
本研究构建了基于犬2型腺病毒(CAV2)的口蹄疫重组疫苗Cav-P1/3C R°和Cav-VP1 R°,分别表达口蹄疫病毒O/FRA/1/2001株的结构P1前体蛋白联合非结构3C蛋白或结构VP1蛋白。豚鼠免疫Cav-P1/3C R°后产生强体液免疫应答,而Cav-VP1 R°在豚鼠或小鼠中未诱导满意的抗体反应。以豚鼠为模型,Cav-P1/3C R°对O1 Manisa/Turkey/1969株攻击的保护程度与高效双油佐剂O1 Manisa疫苗相似。
要点
- Cav-P1/3C R°在豚鼠中诱导强体液免疫应答。
- Cav-VP1 R°在豚鼠或小鼠中未诱导满意的抗体反应。
- Cav-P1/3C R°对豚鼠全身性口蹄疫的保护程度与高效双油佐剂O1 Manisa疫苗相似。
核心结论
- 基于CAV2的载体疫苗可表达免疫原性口蹄疫病毒抗原,并在豚鼠中提供针对全身性口蹄疫的保护。
- 作者认为Cav-P1/3C R°口蹄疫疫苗可能保护自然宿主物种免受口蹄疫。
- 与适当的诊断试验结合,Cav-P1/3C R°口蹄疫疫苗可能作为标记疫苗区分接种与感染动物。
研究设计与样本
- 本研究构建并评价了基于犬2型腺病毒(CAV2)的重组口蹄疫疫苗Cav-P1/3C R°和Cav-VP1 R°。
- Cav-P1/3C R°表达口蹄疫病毒O/FRA/1/2001株的结构P1前体蛋白联合非结构3C蛋白;Cav-VP1 R°表达该株的结构VP1蛋白。
- 在豚鼠和小鼠中评价免疫应答,并以豚鼠为实验模型评价Cav-P1/3C R°对O1 Manisa/Turkey/1969株攻击的保护。
主要发现
- 豚鼠免疫Cav-P1/3C R°后产生强体液免疫应答。
- Cav-VP1 R°在豚鼠或小鼠中未诱导满意的抗体反应。
- Cav-P1/3C R°对豚鼠全身性口蹄疫的保护程度与高效双油佐剂O1 Manisa疫苗相似。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination is a key element in the control of foot-and-mouth disease (FMD). The majority of the antigenic sites that induce protective immune responses are localized on the FMD virus (FMDV) capsid that is formed by four virus-encoded structural proteins, VP1 to VP4. In the present study, recombinant canine adenovirus type 2 (CAV2)-based FMD vaccines, Cav-P1/3C R° and Cav-VP1 R°, respectively expressing the structural P1 precursor protein along with the non-structural 3C protein or expressing the structural VP1 protein of the FMDV strain O/FRA/1/2001, were evaluated as novel vaccines against FMD. A strong humoral immune response was elicited in guinea pigs (GP) following immunization with Cav-P1/3C R°, while administration of Cav-VP1 R° did not induce a satisfying antibody response in GP or mice. GP were then used as an experimental model for the determination of the protection afforded by the Cav-P1/3C R° vaccine against challenge with the FMDV strain O1 Manisa/Turkey/1969. The Cav-P1/3C R° vaccine protected GP from generalized FMD to a similar extent as a high potency double-oil emulsion O1 Manisa vaccine. The results of the present study show that CAV2-based vector vaccines can express immunogenic FMDV antigens and offer protection against generalized FMD in GP. This suggest that Cav-P1/3C R° FMDV vaccine may protect natural host species from FMD. In combination with an appropriate diagnostic test, the Cav-P1/3C R° FMDV vaccine may also serve as a marker vaccine to differentiate vaccinated from infected animals.
引用
- De Vleeschauwer AR, Zhou X, Lefebvre DJ, et al. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs. Vaccine. 2018. PMID: 29544690. doi:10.1016/j.vaccine.2018.02.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。